Replies to post #120 on Seagen Inc (SGEN)

[n4807g]

Dendreon recommended ahead of CMS decision at Canaccord

On Wednesday June 29, 2011, 7:12 am EDT

Canaccord recommends buying Dendreon ahead of the expected positive decision from CMS regarding Provenge reimbursement and the expected FDA approval on its new Orange County facility. Both decisions are expected by June 30. Shares are Buy rated with a $65 price target.

Bulls Eye!

http://finance.yahoo.com/news/Dendreon-recommended-ahead-theflyonthewall-1451936988.html?x=0&.v=1

Their recommendation and $1.09 will get a cup of coffee. Apparently they have entirely discounted the technology, or they want to buy shares.....

[surf1944]

SGEN may be more likely to test a new 52 low in the coming weeks, keep an eye on insider sales as well as what the big holders are filing in the coming weeks:

http://quotes.barrons.com/sgen/ownership

http://www.insidercow.com/history/company.jsp?company=sgen&B1=Search!

In many cases an FDA approval for a biotech stock can be a near term top in the stock.